Cargando…
Ten-Year Experience with Transapical and Direct Transaortic Transcatheter Aortic Valve Replacement to Address Patients with Aortic Stenosis and Peripheral Vascular Disease
Objective: Transcatheter aortic valve replacement (TAVR) through alternative access routes is indicated in patients with severe aortic valve stenosis and diseased peripheral arteries. We analysed and compared the outcome of patients undergoing transapical (TA) and direct transaortic (TAO) TAVR proce...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783693/ https://www.ncbi.nlm.nih.gov/pubmed/36547419 http://dx.doi.org/10.3390/jcdd9120422 |
_version_ | 1784857638291374080 |
---|---|
author | Ferrari, Enrico Pozzoli, Alberto Klersy, Catherine Toto, Francesca Torre, Tiziano Cassina, Tiziano Pedrazzini, Giovanni Demertzis, Stefanos |
author_facet | Ferrari, Enrico Pozzoli, Alberto Klersy, Catherine Toto, Francesca Torre, Tiziano Cassina, Tiziano Pedrazzini, Giovanni Demertzis, Stefanos |
author_sort | Ferrari, Enrico |
collection | PubMed |
description | Objective: Transcatheter aortic valve replacement (TAVR) through alternative access routes is indicated in patients with severe aortic valve stenosis and diseased peripheral arteries. We analysed and compared the outcome of patients undergoing transapical (TA) and direct transaortic (TAO) TAVR procedures. Methods: Preoperative characteristics, procedural details, and thirty-day outcome of patients undergoing transapical (TA-TAVR group) and direct transaortic (TAO-TAVR group) TAVR procedures were prospectively collected and retrospectively analysed. Results: From March 2012 to March 2022, 81 TA and 82 TAO-TAVR (total: 163 cases) were performed with balloon-expanding (n = 120; 73.6%) and self-expandable (n = 43; 26.4%) valves. The mean age was 79.7 ± 6.2 and 81.9 ± 6.7 years for the TA- and TAO-TAVR groups, respectively (p = 0.032). Females were more represented in the TAO-TAVR group (56% vs. 32%; p = 0.003) while TA-TAVR patients showed a higher prevalence of previous vascular surgery (20% vs. 6%; p = 0.01), previous cardiac surgery (51% vs. 3.6%; p < 0.001), and porcelain aorta (22% vs. 5%; p = 0.001). The mean ejection fraction was 49.0 ± 14.6% (TA) and 53.5 ± 12.2% (TAO) (p = 0.035) while mean gradients were 35.6 ± 13.2 mmHg (TA) and 40.4 ± 16.1 mmHg (TAO) (p = 0.045). The median EuroSCORE-II was 5.0% (IQR: 3.0–11.0) and 3.9% (IQR: 2.5–5.4) for the TA- and TAO-TAVR groups, respectively (p = 0.005). The procedural time was shorter for TA procedures (97 min (IQR: 882–118) vs. 102 min (IQR: 88–129); p = 0.133). Mortality at day 30 was 6% in both groups (p = 1.000); the permanent pacemaker implantation rate was similar (8.6% vs. 9.7%; p = 1.000), and hospital stay was shorter for the TAO group (8 days (IQR: 6–11) vs. 10 days (IQR: 7–13); p = 0.025). Conclusions: Our results show that transapical and direct transaortic TAVR in high-risk patients with diseased peripheral arteries provide satisfactory clinical results with similar thirty-day outcomes. |
format | Online Article Text |
id | pubmed-9783693 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97836932022-12-24 Ten-Year Experience with Transapical and Direct Transaortic Transcatheter Aortic Valve Replacement to Address Patients with Aortic Stenosis and Peripheral Vascular Disease Ferrari, Enrico Pozzoli, Alberto Klersy, Catherine Toto, Francesca Torre, Tiziano Cassina, Tiziano Pedrazzini, Giovanni Demertzis, Stefanos J Cardiovasc Dev Dis Article Objective: Transcatheter aortic valve replacement (TAVR) through alternative access routes is indicated in patients with severe aortic valve stenosis and diseased peripheral arteries. We analysed and compared the outcome of patients undergoing transapical (TA) and direct transaortic (TAO) TAVR procedures. Methods: Preoperative characteristics, procedural details, and thirty-day outcome of patients undergoing transapical (TA-TAVR group) and direct transaortic (TAO-TAVR group) TAVR procedures were prospectively collected and retrospectively analysed. Results: From March 2012 to March 2022, 81 TA and 82 TAO-TAVR (total: 163 cases) were performed with balloon-expanding (n = 120; 73.6%) and self-expandable (n = 43; 26.4%) valves. The mean age was 79.7 ± 6.2 and 81.9 ± 6.7 years for the TA- and TAO-TAVR groups, respectively (p = 0.032). Females were more represented in the TAO-TAVR group (56% vs. 32%; p = 0.003) while TA-TAVR patients showed a higher prevalence of previous vascular surgery (20% vs. 6%; p = 0.01), previous cardiac surgery (51% vs. 3.6%; p < 0.001), and porcelain aorta (22% vs. 5%; p = 0.001). The mean ejection fraction was 49.0 ± 14.6% (TA) and 53.5 ± 12.2% (TAO) (p = 0.035) while mean gradients were 35.6 ± 13.2 mmHg (TA) and 40.4 ± 16.1 mmHg (TAO) (p = 0.045). The median EuroSCORE-II was 5.0% (IQR: 3.0–11.0) and 3.9% (IQR: 2.5–5.4) for the TA- and TAO-TAVR groups, respectively (p = 0.005). The procedural time was shorter for TA procedures (97 min (IQR: 882–118) vs. 102 min (IQR: 88–129); p = 0.133). Mortality at day 30 was 6% in both groups (p = 1.000); the permanent pacemaker implantation rate was similar (8.6% vs. 9.7%; p = 1.000), and hospital stay was shorter for the TAO group (8 days (IQR: 6–11) vs. 10 days (IQR: 7–13); p = 0.025). Conclusions: Our results show that transapical and direct transaortic TAVR in high-risk patients with diseased peripheral arteries provide satisfactory clinical results with similar thirty-day outcomes. MDPI 2022-11-28 /pmc/articles/PMC9783693/ /pubmed/36547419 http://dx.doi.org/10.3390/jcdd9120422 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ferrari, Enrico Pozzoli, Alberto Klersy, Catherine Toto, Francesca Torre, Tiziano Cassina, Tiziano Pedrazzini, Giovanni Demertzis, Stefanos Ten-Year Experience with Transapical and Direct Transaortic Transcatheter Aortic Valve Replacement to Address Patients with Aortic Stenosis and Peripheral Vascular Disease |
title | Ten-Year Experience with Transapical and Direct Transaortic Transcatheter Aortic Valve Replacement to Address Patients with Aortic Stenosis and Peripheral Vascular Disease |
title_full | Ten-Year Experience with Transapical and Direct Transaortic Transcatheter Aortic Valve Replacement to Address Patients with Aortic Stenosis and Peripheral Vascular Disease |
title_fullStr | Ten-Year Experience with Transapical and Direct Transaortic Transcatheter Aortic Valve Replacement to Address Patients with Aortic Stenosis and Peripheral Vascular Disease |
title_full_unstemmed | Ten-Year Experience with Transapical and Direct Transaortic Transcatheter Aortic Valve Replacement to Address Patients with Aortic Stenosis and Peripheral Vascular Disease |
title_short | Ten-Year Experience with Transapical and Direct Transaortic Transcatheter Aortic Valve Replacement to Address Patients with Aortic Stenosis and Peripheral Vascular Disease |
title_sort | ten-year experience with transapical and direct transaortic transcatheter aortic valve replacement to address patients with aortic stenosis and peripheral vascular disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783693/ https://www.ncbi.nlm.nih.gov/pubmed/36547419 http://dx.doi.org/10.3390/jcdd9120422 |
work_keys_str_mv | AT ferrarienrico tenyearexperiencewithtransapicalanddirecttransaortictranscatheteraorticvalvereplacementtoaddresspatientswithaorticstenosisandperipheralvasculardisease AT pozzolialberto tenyearexperiencewithtransapicalanddirecttransaortictranscatheteraorticvalvereplacementtoaddresspatientswithaorticstenosisandperipheralvasculardisease AT klersycatherine tenyearexperiencewithtransapicalanddirecttransaortictranscatheteraorticvalvereplacementtoaddresspatientswithaorticstenosisandperipheralvasculardisease AT totofrancesca tenyearexperiencewithtransapicalanddirecttransaortictranscatheteraorticvalvereplacementtoaddresspatientswithaorticstenosisandperipheralvasculardisease AT torretiziano tenyearexperiencewithtransapicalanddirecttransaortictranscatheteraorticvalvereplacementtoaddresspatientswithaorticstenosisandperipheralvasculardisease AT cassinatiziano tenyearexperiencewithtransapicalanddirecttransaortictranscatheteraorticvalvereplacementtoaddresspatientswithaorticstenosisandperipheralvasculardisease AT pedrazzinigiovanni tenyearexperiencewithtransapicalanddirecttransaortictranscatheteraorticvalvereplacementtoaddresspatientswithaorticstenosisandperipheralvasculardisease AT demertzisstefanos tenyearexperiencewithtransapicalanddirecttransaortictranscatheteraorticvalvereplacementtoaddresspatientswithaorticstenosisandperipheralvasculardisease |